Recursion (Nasdaq: RXRX) said on Wednesday that it had named Vicki Goodman as chief medical officer, effective April 6, 2026, succeeding David Mauro. Goodman had more than two decades of experience in ...

RXRX is trading near the bottom of its 52-week range and below its 200-day simple moving average. Price change The price of RXRX shares has decreased $0.22 since the market last closed. This is a 5.90 ...

Learn coding in Python, Go and Rust from Serdar Yegulalp, software dev specialist and senior writer at InfoWorld. Python 3.15 has introduced a feature to allow "lazy" module imports, where an imported ...

Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company that combines automation, artificial intelligence, machine learning, and in vivo validation capabilities to discover novel ...